ConductScience.org, home

Trial · NCT06285539

Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases

NCT06285539, Phase 2, Recruiting, UMC Utrecht

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases. Trials, record NCT06285539. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06285539

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases
NCT number
NCT06285539
Status
Recruiting
Phases
Phase 2
Enrollment
60 participants, estimated
Lead sponsor
UMC Utrecht
Conditions
Behcet's Disease, Idiopathic Inflammatory Myopathies, IgG4-related Disease
Interventions
Filgotinib
First posted
2024-02-29
Last updated
2026-05-12

Source ClinicalTrials.gov

Registered outcomes9

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryEQ-5D-5L26 weeksChange from baseline in EuroQoL-5D-5L
PrimaryDisease activity in Behcet's patients26 weeksChange from baseline in Behcet's Disease Current Activity Form (BDCAF)
PrimaryDisease activity in myositis patients26 weeksChange from baseline in Total Improvement Score (TIS) of the International Myositis Assessment Clinical Studies (IMACS) group
PrimaryDisease activity in IgG4-RD patients26 weeksChange from baseline in IgG4-RD responder index
SecondaryCorticosteroid toxicity26 weeksChange from baseline in Glucocorticoid Toxicity Index (GTI)
SecondaryCorticosteroid dosage26 weeksChange from baseline in glucocorticoid dose
SecondaryVAS score of pain26 weeksChange from baseline in pain scores on the Visual Analog Scale (0-100mm). A higher score is a worse outcome
SecondaryFatigue26 weeksChange from baseline in fatigue scores on the Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F). A higher score is a worse outcome
SecondaryTreatment-related adverse events26 weeksNumber of Participants With Treatment-Related Adverse Events as Assessed by CTCAE v4.0

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
39915014DERIVED

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06285539

GET https://conductscience.org/api/trials/v1/NCT06285539/registered